We are live on ! Find out more
CHTP

CHELSEA THERAPEUTICS INT'L LTD
CHTP

Delisted

CHTP was delisted on the 23rd of June, 2014.

Back to rankings

69 hedge funds and large institutions have $79.5M invested in CHELSEA THERAPEUTICS INT'L LTD in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 12

143% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 7

41% more capital invested

Capital invested by funds: $56.3M → $79.5M (+$23.2M)

23% more call options, than puts

Call options by funds: $1.74M | Put options by funds: $1.41M

13% more funds holding

Funds holding: 61 → 69 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
69
Holders Change
+8
Holders Change %
+13.11%
% of All Funds
2.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
32
Reduced
12
Closed
7
Calls
$1.74M
Puts
$1.41M
Net Calls
+$325K
Net Calls Change
+$840K

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$2.93M
2
JGC
J. Goldman & Co
New York
+$1.83M
3
Northern Trust
Northern Trust
Illinois
+$1.57M
4
EI
EAM Investors
California
+$1.3M
5
BFA
BlackRock Fund Advisors
California
+$633K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$3.56M
2
TC
TFS Capital
Pennsylvania
-$1.08M
3
BIT
BlackRock Institutional Trust
California
-$470K
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$354K
5
Goldman Sachs
Goldman Sachs
New York
-$345K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
26
Highbridge Capital Management
New York
$335K +$321K +111,614 New
Charles Schwab
27
Charles Schwab
California
$292K – – –
TA
28
Teachers Advisors
New York
$289K +$28.5K +9,913 +11%
PPA
29
Parametric Portfolio Associates
Washington
$279K +$268K +93,322 New
AQR Capital Management
30
AQR Capital Management
Connecticut
$252K +$240K +83,600 New
Goldman Sachs
31
Goldman Sachs
New York
$246K -$345K -120,220 -59%
DS
32
DRW Securities
Illinois
$236K +$230K +80,012 New
Millennium Management
33
Millennium Management
New York
$233K +$224K +78,065 New
CS
34
Credit Suisse
Switzerland
$219K +$172K +59,733 +451%
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$211K +$99.1K +34,507 +97%
OAM
36
Oxford Asset Management
United Kingdom
$192K +$56.1K +19,534 +44%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$189K +$1.45K +503 +0.8%
MLICM
38
Metropolitan Life Insurance Company (MetLife)
New York
$183K +$174K +60,652 New
AIG
39
American International Group
New York
$165K +$129K +44,968 +450%
NFA
40
Nationwide Fund Advisors
Ohio
$161K +$91.8K +31,969 +149%
EEG
41
E.E. Geduld
$150K +$71.8K +25,000 +100%
Citadel Advisors
42
Citadel Advisors
Florida
$150K +$117K +40,904 +457%
Connor, Clark & Lunn Investment Management (CC&L)
43
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$149K +$139K +48,522 New
VKH
44
Virtu KCG Holdings
New York
$141K +$135K +47,154 New
Bank of America
45
Bank of America
North Carolina
$128K -$335K -116,493 -73%
BA
46
BlackRock Advisors
Delaware
$128K +$8.13K +2,832 +7%
ProShare Advisors
47
ProShare Advisors
Maryland
$128K +$122K +42,377 New
Barclays
48
Barclays
United Kingdom
$123K +$94.6K +32,941 +115%
U
49
UBS
Switzerland
$122K -$339K -118,143 -74%
Principal Financial Group
50
Principal Financial Group
Iowa
$101K +$96.1K +33,448 New
1
2
3 4

CHTP Hedge Fund Activity: Q3 2013 in Review

69 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in CHELSEA THERAPEUTICS INT'L LTD (CHTP) for Q3 2013, worth a combined $79.5M — up 41% from $56.3M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CHTP positions and 7 closed out — a net gain of 10 holders — while 32 added to existing stakes and 12 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $2.93M. The largest seller was Perceptive Advisors, cutting an estimated $3.56M.

  • 69 institutional investors held CHELSEA THERAPEUTICS INT'L LTD (CHTP) as of Q3 2013, up from 61 in Q2 2013.
  • Funds reported $79.5M of CHELSEA THERAPEUTICS INT'L LTD stock for Q3 2013, up 41% quarter-over-quarter.
  • 17 funds opened new CHELSEA THERAPEUTICS INT'L LTD positions in Q3 2013 and 7 closed out, a net change of +10 holders.
  • The largest CHELSEA THERAPEUTICS INT'L LTD buyer in Q3 2013 was Baker Bros. Advisors, an estimated $2.93M added.
  • The largest CHELSEA THERAPEUTICS INT'L LTD seller in Q3 2013 was Perceptive Advisors, an estimated $3.56M sold.

Based on aggregated 13F filings for Q3 2013.